Trials / NCT03626207
Development of Visual Function Evaluation Method (2)
Completed Observational Natural history / observational
- Sponsor
- Astellas Pharma Inc
- Treatment
- Not listed
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- 20 Years to no upper limit
- Enrollment
- 8 participants
- Started
- 2018-10-04
- Main results expected
- 2019-06-26
- Results posted
- Not yet
- Record last updated
- 2024-10-21
What the study is testing
The objective of this study is to develop the comprehensive visual function evaluation method in severe visually impaired patient.
Where it runs
Japan (1)
- Site JP00001, Kobe, Hyōgo